1. Home
  2. West Africa
  3. Nigeria
  • News

AIDS treatment makes strides despite past hurdles

Nigeria said on Tuesday that the number of HIV-positive people receiving free anti-AIDS drugs has risen five-fold over the past three years to 50,000. According to Babatunde Osotimehin, chairman of the National Action Committee Against AIDS (NACA), plans to achieve a treatment target of 250,000 by next year were on course, although the necessary funds were still not in place. Reuters quoted Osotimehin as saying: "We are optimistic of achieving that target - we are already working with our partners and also reaching out to raise more resources to meet the deadline." Nigeria's national antiretroviral rollout programme was nearly crippled by funding problems last year, but was resuscitated by donor support from the US, the Global AIDS Fund and the private sector.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join